428 related articles for article (PubMed ID: 28468969)
1. Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation.
Gibson SA; Yang W; Yan Z; Liu Y; Rowse AL; Weinmann AS; Qin H; Benveniste EN
J Immunol; 2017 Jun; 198(11):4244-4254. PubMed ID: 28468969
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation.
Jang SW; Hwang SS; Kim HS; Lee KO; Kim MK; Lee W; Kim K; Lee GR
Exp Mol Med; 2017 Sep; 49(9):e375. PubMed ID: 28883547
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.
Ulges A; Witsch EJ; Pramanik G; Klein M; Birkner K; Bühler U; Wasser B; Luessi F; Stergiou N; Dietzen S; Brühl TJ; Bohn T; Bündgen G; Kunz H; Waisman A; Schild H; Schmitt E; Zipp F; Bopp T
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10145-50. PubMed ID: 27555590
[TBL] [Abstract][Full Text] [Related]
4. CK2 Controls Th17 and Regulatory T Cell Differentiation Through Inhibition of FoxO1.
Gibson SA; Yang W; Yan Z; Qin H; Benveniste EN
J Immunol; 2018 Jul; 201(2):383-392. PubMed ID: 29891553
[TBL] [Abstract][Full Text] [Related]
5. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
6. Protein Kinase CK2: An Emerging Regulator of Immunity.
Gibson SA; Benveniste EN
Trends Immunol; 2018 Feb; 39(2):82-85. PubMed ID: 29307449
[TBL] [Abstract][Full Text] [Related]
7. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
[TBL] [Abstract][Full Text] [Related]
8. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
9. A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg balance.
Aqel SI; Yang X; Kraus EE; Song J; Farinas MF; Zhao EY; Pei W; Lovett-Racke AE; Racke MK; Li C; Yang Y
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33411696
[TBL] [Abstract][Full Text] [Related]
10. Protein translocation and retro-translocation across the endoplasmic reticulum are crucial to inflammatory effector CD4
Pradeep Yeola A; Akbar I; Baillargeon J; Mercy Ignatius Arokia Doss P; Paavilainen VO; Rangachari M
Cytokine; 2020 May; 129():154944. PubMed ID: 32146280
[TBL] [Abstract][Full Text] [Related]
11. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
12. CD5 enhances Th17-cell differentiation by regulating IFN-γ response and RORγt localization.
McGuire DJ; Rowse AL; Li H; Peng BJ; Sestero CM; Cashman KS; De Sarno P; Raman C
Eur J Immunol; 2014 Apr; 44(4):1137-42. PubMed ID: 24356888
[TBL] [Abstract][Full Text] [Related]
13. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
14. CD5-dependent CK2 activation pathway regulates threshold for T cell anergy.
Sestero CM; McGuire DJ; De Sarno P; Brantley EC; Soldevila G; Axtell RC; Raman C
J Immunol; 2012 Sep; 189(6):2918-30. PubMed ID: 22904299
[TBL] [Abstract][Full Text] [Related]
15. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
You Z; Timilshina M; Jeong BS; Chang JH
Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
[TBL] [Abstract][Full Text] [Related]
16. SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance.
Li J; Jing J; Bai Y; Li Z; Xing R; Tan B; Ma X; Qiu WW; Du C; Du B; Yang F; Tang J; Siwko S; Liu M; Chen H; Luo J
Mol Pharmacol; 2017 May; 91(5):464-474. PubMed ID: 28213589
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C θ regulates the phenotype of murine CD4+ Th17 cells.
Wachowicz K; Hermann-Kleiter N; Meisel M; Siegmund K; Thuille N; Baier G
PLoS One; 2014; 9(5):e96401. PubMed ID: 24788550
[TBL] [Abstract][Full Text] [Related]
18. Casein Kinase II exacerbates rheumatoid arthritis via promoting Th1 and Th17 cell inflammatory responses.
Ye H; Fu D; Fang X; Xie Y; Zheng X; Fan W; Hu F; Li Z
Expert Opin Ther Targets; 2021 Nov; 25(11):1017-1024. PubMed ID: 34806506
[TBL] [Abstract][Full Text] [Related]
19. Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4
Sacramento PM; Monteiro C; Dias ASO; Kasahara TM; Ferreira TB; Hygino J; Wing AC; Andrade RM; Rueda F; Sales MC; Vasconcelos CC; Bento CAM
Eur J Immunol; 2018 Aug; 48(8):1376-1388. PubMed ID: 29719048
[TBL] [Abstract][Full Text] [Related]
20. RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis.
Rus V; Nguyen V; Tatomir A; Lees JR; Mekala AP; Boodhoo D; Tegla CA; Luzina IG; Antony PA; Cudrici CD; Badea TC; Rus HG
J Immunol; 2017 May; 198(10):3869-3877. PubMed ID: 28356385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
